Efficacy and Safety of tacalcitol ointment(20mcg/g) in Psoriasis Vulgaris - Double blind inter-group study compared with tacalcitol ointment(2mcg/g)(Study to obtain IDL)

Phase 3

• Conditions: Psoriasis Vulgaris

• Registration Number: JPRN-jRCT2080220840
• Lead Sponsor: TEIJIN PHARMA LIMITED

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-09-03
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Sex: All
• Target Recruitment: 240

Inclusion Criteria

Psoriasis vulgaris

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Efficacy and safety